Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
EVH 
Evolent Health Inc (EVH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: EVH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $15.08
1 Year Target Price $15.08
| 9 | Strong Buy |
| 4 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -25.44% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.31B USD | Price to earnings Ratio - | 1Y Target Price 15.08 |
Price to earnings Ratio - | 1Y Target Price 15.08 | ||
Volume (30-day avg) 14 | Beta 0.89 | 52 Weeks Range 7.06 - 33.63 | Updated Date 06/30/2025 |
52 Weeks Range 7.06 - 33.63 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-06-06 | When Before Market | Estimate 0.24 | Actual 0.06 |
Profitability
Profit Margin -4.54% | Operating Margin (TTM) 0.35% |
Management Effectiveness
Return on Assets (TTM) -0.04% | Return on Equity (TTM) -9.24% |
Valuation
Trailing PE - | Forward PE 28.65 | Enterprise Value 1933731879 | Price to Sales(TTM) 0.55 |
Enterprise Value 1933731879 | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 0.81 | Enterprise Value to EBITDA 59.38 | Shares Outstanding 117400000 | Shares Floating 103474239 |
Shares Outstanding 117400000 | Shares Floating 103474239 | ||
Percent Insiders 1.41 | Percent Institutions 109.46 |
Analyst Ratings
Rating 4 | Target Price 15.08 | Buy 4 | Strong Buy 9 |
Buy 4 | Strong Buy 9 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Evolent Health Inc
Company Overview
History and Background
Evolent Health Inc. was founded in 2011. It focuses on partnering with health plans and providers to manage complex healthcare populations. It evolved from a venture capital initiative to a publicly traded company providing administrative and clinical solutions.
Core Business Areas
- Evolent Value-Based Care: Provides solutions to help health systems and physician organizations transition to value-based care models, improve clinical outcomes, and reduce costs.
- Evolent Health Plan Services: Offers comprehensive administrative and clinical solutions for health plans, including utilization management, care management, and population health analytics.
- New Century Health: Specializes in oncology and cardiology care management, providing evidence-based guidelines and technology to improve patient care and reduce costs. (Acquired by Evolent)
Leadership and Structure
The leadership team typically consists of a CEO, CFO, CTO, and other executive officers overseeing various departments. The organizational structure includes functional departments such as operations, finance, technology, and sales/marketing.
Top Products and Market Share
Key Offerings
- Identifi Platform: A technology platform that aggregates clinical and claims data to provide insights for care management and population health. Market share data is not directly available, but Identifi supports a significant portion of Evolent's managed lives. Competitors include companies like Optum, Cerner, and Allscripts.
- Value-Based Care Solutions: Consulting and management services to assist providers in transitioning to value-based payment models, focusing on cost reduction and quality improvement. Competitors include companies such as Premier Inc., and Conifer Health Solutions.
- New Century Health Care Management Programs: Provide evidence-based oncology and cardiology care management services. Competitors include companies like Cardinal Health and McKesson.
Market Dynamics
Industry Overview
The healthcare industry is shifting towards value-based care models, with increasing emphasis on data analytics, care coordination, and population health management. Demand is growing for solutions that help providers and health plans improve outcomes and reduce costs.
Positioning
Evolent Health Inc. is positioned as a partner to health plans and providers, offering technology and services to support their transition to value-based care. Competitive advantages include its Identifi platform and expertise in complex care management.
Total Addressable Market (TAM)
The TAM for value-based care solutions is estimated to be in the tens of billions of dollars, considering the ongoing shift in the U.S. healthcare system. Evolent is positioned to capture a portion of this market through its partnerships and integrated solutions.
Upturn SWOT Analysis
Strengths
- Strong technology platform (Identifi)
- Expertise in value-based care
- Established partnerships with health plans and providers
- Specialized care management programs (e.g., oncology, cardiology)
Weaknesses
- Dependence on a limited number of key clients
- Competition from larger, more diversified healthcare companies
- Integration challenges with acquired companies
- Profitability concerns in the past
Opportunities
- Expansion into new geographic markets
- Growth in demand for value-based care solutions
- Development of new products and services
- Strategic acquisitions and partnerships
Threats
- Changes in healthcare regulations
- Increased competition
- Economic downturn
- Data security and privacy breaches
Competitors and Market Share
Key Competitors
- OTLY
- THC
- ACAD
- AMN
- MEDP
Competitive Landscape
Evolent Health Inc. competes with larger and smaller companies offering similar solutions. Its strengths include its integrated technology platform and expertise in value-based care, while weaknesses may include its smaller size and dependence on key clients.
Major Acquisitions
New Century Health
- Year: 2018
- Acquisition Price (USD millions): 650
- Strategic Rationale: Expanded Evolent's capabilities in oncology and cardiology care management.
Growth Trajectory and Initiatives
Historical Growth: Evolent Health Inc. has experienced revenue growth driven by demand for value-based care solutions. Specific growth rates vary and can be found in financial reports.
Future Projections: Future growth projections vary depending on analyst estimates. Refer to financial news sources and analyst reports for projections.
Recent Initiatives: Recent initiatives include expanding partnerships with health systems, launching new care management programs, and investing in technology.
Summary
Evolent Health is a company focused on value-based care that has shown revenue growth. Key strengths include technology and partnerships. However, it needs to manage competition from larger players and ensure consistent profitability. The future success is dependent on the continuing adoption of value-based care models.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q)
- Analyst reports
- Press releases
- Industry publications
Disclaimers:
This analysis is based on publicly available information and represents a general overview. Investment decisions should be based on individual research and professional advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4500 | Website https://www.evolent.com |
Full time employees 4500 | Website https://www.evolent.com | ||
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.